Free Trial

Waters (WAT) Competitors

Waters logo
$358.46 -18.26 (-4.85%)
(As of 11/15/2024 ET)

WAT vs. A, MTD, ILMN, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMO

Should you be buying Waters stock or one of its competitors? The main competitors of Waters include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry.

Waters vs.

Waters (NYSE:WAT) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, community ranking, media sentiment, dividends, institutional ownership, valuation and profitability.

Waters currently has a consensus price target of $365.85, suggesting a potential upside of 2.06%. Agilent Technologies has a consensus price target of $144.36, suggesting a potential upside of 13.60%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Agilent Technologies is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waters
1 Sell rating(s)
10 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.27
Agilent Technologies
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Waters had 11 more articles in the media than Agilent Technologies. MarketBeat recorded 25 mentions for Waters and 14 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.20 beat Waters' score of 0.30 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waters
7 Very Positive mention(s)
5 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Agilent Technologies
11 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agilent Technologies has a net margin of 21.75% compared to Waters' net margin of 21.43%. Waters' return on equity of 49.93% beat Agilent Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Waters21.43% 49.93% 14.96%
Agilent Technologies 21.75%25.26%14.00%

94.0% of Waters shares are owned by institutional investors. 0.8% of Waters shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Agilent Technologies received 426 more outperform votes than Waters when rated by MarketBeat users. Likewise, 71.25% of users gave Agilent Technologies an outperform vote while only 53.51% of users gave Waters an outperform vote.

CompanyUnderperformOutperform
WatersOutperform Votes
434
53.51%
Underperform Votes
377
46.49%
Agilent TechnologiesOutperform Votes
860
71.25%
Underperform Votes
347
28.75%

Waters has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.96B7.20$642.23M$10.4834.20
Agilent Technologies$6.83B5.34$1.24B$4.8226.36

Summary

Agilent Technologies beats Waters on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WAT vs. The Competition

MetricWatersAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$21.28B$5.10B$5.12B$19.76B
Dividend YieldN/A0.43%5.18%3.50%
P/E Ratio34.2010.7572.8137.06
Price / Sales7.203.931,250.2017.77
Price / Cash24.5844.4240.7021.54
Price / Book13.282.206.454.64
Net Income$642.23M$515,312.50$119.73M$982.94M
7 Day Performance-6.77%-11.04%-5.13%-2.12%
1 Month Performance3.21%-7.68%-2.71%-0.39%
1 Year Performance36.88%-16.52%31.08%23.34%

Waters Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WAT
Waters
4.1617 of 5 stars
$358.46
-4.8%
$365.85
+2.1%
+34.7%$21.28B$2.96B34.207,900
A
Agilent Technologies
4.7546 of 5 stars
$133.86
-2.1%
N/A+11.3%$38.46B$6.50B27.7718,100Short Interest ↑
Positive News
High Trading Volume
MTD
Mettler-Toledo International
4.0274 of 5 stars
$1,250.07
-4.6%
N/A+12.4%$26.53B$3.76B33.7017,300High Trading Volume
ILMN
Illumina
4.3693 of 5 stars
$151.50
+0.3%
N/A+41.9%$24.03B$4.50B-15.219,300Analyst Forecast
Positive News
TECH
Bio-Techne
4.8317 of 5 stars
$74.69
-1.7%
N/A+11.0%$11.87B$1.16B79.463,100Analyst Upgrade
CRL
Charles River Laboratories International
4.7758 of 5 stars
$220.69
+2.5%
N/A-0.9%$11.29B$4.13B27.6221,800Insider Selling
Short Interest ↓
BIO
Bio-Rad Laboratories
4.6947 of 5 stars
$365.95
-0.9%
N/A+5.2%$10.25B$2.67B-13.398,030Short Interest ↓
News Coverage
Positive News
BRKR
Bruker
4.9945 of 5 stars
$56.65
-1.9%
N/A-16.5%$8.58B$2.96B27.249,707Short Interest ↓
PACB
Pacific Biosciences of California
2.1896 of 5 stars
$2.46
+7.0%
N/A-79.0%$670.42M$173.15M-1.68730Analyst Upgrade
Analyst Revision
HBIO
Harvard Bioscience
1.2093 of 5 stars
$2.45
-4.7%
N/A-49.8%$106.85M$112.25M-7.42490Short Interest ↑
TMO
Thermo Fisher Scientific
4.9918 of 5 stars
$546.92
-0.9%
N/A+8.6%$209.20B$42.86B34.29122,000Insider Selling
Buyback Announcement
Analyst Revision
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:WAT) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners